initiated a Phase 3 clinical trial for its investigational GLP-1 agonist compound MariTide, targeting obesity and cardiometabolic comorbidities
NSF Certified, GMP compliant, and made in the USA with premium ingredients
Trial page For laboratory and research use only
Some patients may respond well to lower-dose approaches, but most long-term clinical evidence is based on standard dosing protocols
Potential side effects Possible side effects of supplementary l-carnitine include, but are not limited to: Gut disturbance: l-carnitine does not have an established upper intake level, although doses above 3g per day may cause nausea, vomiting, abdominal cramps and diarrhoea Coronary artery disease: some research suggests l-carnitine may be linked to an increased risk of coronary artery disease and heart failure, especially in men and those who eat meat
#ObesityMedicine #GLP1 #Semaglutide #Tirzepatide #Nutrition #SarcopenicObesity #DiabetesCare #LifestyleMedicine #PrecisionNutrition Dr Paramesh Shamanna - - . A new Cell Metabolism paper (Qin et al., 2026) asks a provocative question: what if some of the biggest benefits of semaglutide come from metabolic restoration inside tissues, even when weight loss is controlled for